Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
112.26
+0.11 (0.10%)
At close: Mar 28, 2025, 4:00 PM
109.35
-2.91 (-2.59%)
After-hours: Mar 28, 2025, 6:21 PM EDT
Zimmer Biomet Holdings Revenue
In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth. Zimmer Biomet Holdings had revenue of $2.02B in the quarter ending December 31, 2024, with 4.28% growth.
Revenue (ttm)
$7.68B
Revenue Growth
+3.85%
P/S Ratio
2.97
Revenue / Employee
$451,682
Employees
17,000
Market Cap
22.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
| Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
| Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
| Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
| Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
ZBH News
- 17 days ago - Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act - Business Wire
- 18 days ago - Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting - PRNewsWire
- 21 days ago - Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur - PRNewsWire
- 22 days ago - Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer - PRNewsWire
- 4 weeks ago - Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference - PRNewsWire
- 4 weeks ago - Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer - PRNewsWire
- 4 weeks ago - Zimmer Biomet Launches You'll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger - PRNewsWire
- 4 weeks ago - Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025 - PRNewsWire